www.sciencedirect.com/science/article/pii/S2468024925007077/ For people with a clinical high-risk for psychosis , 12 weeks of PEA reduced psychotic symptoms, possibly via immune & inflammatory modulations Effects of palmitoylethanolamide in clinical high-risk for psychosis: A nonrandomized open-label trial https

Use_of_cannabidiol_in_the_management_of_refractory_seizures_in_Lafora_disease_A_case_report_of_two_siblings_Case_Report_Journal_of_Clinical_Images_and_Medical_Case_Reports   For cannabis helping with recovery from psychosis Hoe cannabis mijn herstel van psychose bevorderd heft [Recovered or Not Recovered? How Cannabis Aided My Recovery from Psychosis] https://www.tijdschriftvoorpsychiatrie.nl/en/artikelen /article/50-13509_Hersteld-of-niet-hersteld-Hoe-cannabis-mijn-herstel-van-psychose-bevorderd-heeft For

Prospective_Analysis_of_Cannabidiol's_Effectiveness_in_Post-Exercise_Recovery_An_integrative_Systematic_Review_and_Research_Agenda In people with psychosis or at ultra-high risk for psychosis, a review of 13 studies found CBD helped with positive & negative correlates with positive and negative symptom improvement following cannabidiol (CBD) administration in psychosis

Disorders: A Scoping Review https://link.springer.com/article/10.1007/s40261-025-01501-3 In prodromal psychosis on the ECS as a therapeutic target The endocannabinoid system as a therapeutic target in prodromal psychosis

In patients at a high risk of psychosis, CBD helped to normalize the levels of glutamate in their hippocampus suggesting a protective effect Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis

https://www.sciencedirect.com/science/article/abs/pii/S073708062300309X A review of drugs to treat psychosis find help from CBD Use of psychoactive substances as a treatment for psychosis https://pubmed.ncbi.nlm.nih.gov

and integrated perspective https://pubmed.ncbi.nlm.nih.gov/37385352/ A review of 13 studies of PEA in psychosis finds its potential as a psychosis biomarker as well as a potential therapeutic treatment Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

with a Systematic Approach https://pubmed.ncbi.nlm.nih.gov/36901098/ In people with a high risk for psychosis the brain) Acute Effects of Cannabidiol on Hippocampal Blood Flow in People at Clinical High Risk for Psychosis

In patients with early psychosis, one dose of CBD lowered activity in the insula (a brain region associated Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis

Osteopenia: A Case Series https://pubmed.ncbi.nlm.nih.gov/37721991/# In people at clinical high risk for psychosis normalize their hippocampal blood flow Increased Hippocampal Blood Flow in People at Clinical High Risk for Psychosis

patients with dystonia https://pubmed.ncbi.nlm.nih.gov/37456642/ In brain scans of people at risk for psychosis with 600 milligrams of CBD Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis

Are-Cannabis-Based-Medicines-a-Useful-Treatment-for-Neuropathic-Pain-A-Systematic-Review.pdf   For CBD & cognition, a review of 36 studies looked at effects for Parkinson's disease, anxiety, psychosis